These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25073780)

  • 21. Substance use in rural Midwestern pregnant women.
    Yawn BP; Yawn RA; Uden DL
    Arch Fam Med; 1992 Sep; 1(1):83-8. PubMed ID: 1341592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prenatal drug use in Minneapolis-St Paul, Minn. A 4-year trend.
    Yawn BP; Thompson LR; Lupo VR; Googins MK; Yawn RA
    Arch Fam Med; 1994 Jun; 3(6):520-7. PubMed ID: 8081532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. False-positive and false-negative rates in meconium drug testing.
    Moore C; Lewis D; Leikin J
    Clin Chem; 1995 Nov; 41(11):1614-6. PubMed ID: 7586551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report.
    Lester BM; ElSohly M; Wright LL; Smeriglio VL; Verter J; Bauer CR; Shankaran S; Bada HS; Walls HH; Huestis MA; Finnegan LP; Maza PL
    Pediatrics; 2001 Feb; 107(2):309-17. PubMed ID: 11158464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal trends in meconium drug detection in 46 US states between the years 2015 and 2020.
    Pandya V; Wilker C; Johnson-Davis KL
    J Anal Toxicol; 2023 Jul; 47(6):495-503. PubMed ID: 37079848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of cocaine exposure in the neonate. Analyses of urine, meconium, and amniotic fluid from mothers and infants exposed to cocaine.
    Casanova OQ; Lombardero N; Behnke M; Eyler FD; Conlon M; Bertholf RL
    Arch Pathol Lab Med; 1994 Oct; 118(10):988-93. PubMed ID: 7944901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement of gestational cocaine exposure: sensitivity of infants' hair, meconium, and urine.
    Callahan CM; Grant TM; Phipps P; Clark G; Novack AH; Streissguth AP; Raisys VA
    J Pediatr; 1992 May; 120(5):763-8. PubMed ID: 1578314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Association Between Antenatal Maternal Self-reported Substance Use, Maternal Characteristics, and Obstetrical Variables.
    Berra A; Kamo S; Mohnot S; Rosselot J; Suire A; Stafford J; Hagan J; Stafford I
    J Addict Med; 2019; 13(6):464-469. PubMed ID: 31033670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastric fluid analysis for determining gestational cocaine exposure.
    Garcia DC; Romero A; Garcia GC; Ostrea EM
    Pediatrics; 1996 Aug; 98(2 Pt 1):291-3. PubMed ID: 8692634
    [No Abstract]   [Full Text] [Related]  

  • 30. A Prediction Model for Positive Infant Meconium and Urine Drug Tests.
    Simpson EA; Skoglund DA; Stone SE; Sherman AK
    Am J Perinatol; 2022 Jul; 39(10):1104-1111. PubMed ID: 33336348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoassay and GC-MS procedures for the analysis of drugs of abuse in meconium.
    ElSohly MA; Stanford DF; Murphy TP; Lester BM; Wright LL; Smeriglio VL; Verter J; Bauer CR; Shankaran S; Bada HS; Walls HC
    J Anal Toxicol; 1999 Oct; 23(6):436-45. PubMed ID: 10517548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimating community drug abuse by wastewater analysis.
    Zuccato E; Chiabrando C; Castiglioni S; Bagnati R; Fanelli R
    Environ Health Perspect; 2008 Aug; 116(8):1027-32. PubMed ID: 18709161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meconium analysis for improved identification of infants exposed to cocaine in utero.
    Ryan RM; Wagner CL; Schultz JM; Varley J; DiPreta J; Sherer DM; Phelps DL; Kwong T
    J Pediatr; 1994 Sep; 125(3):435-40. PubMed ID: 8071754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of New Psychoactive Substances (NPS) and conventional drugs of abuse (DOA) in high risk populations from Paris (France) and its suburbs: A cross sectional study by hair testing (2012-2017).
    Larabi IA; Fabresse N; Etting I; Nadour L; Pfau G; Raphalen JH; Philippe P; Edel Y; Alvarez JC
    Drug Alcohol Depend; 2019 Nov; 204():107508. PubMed ID: 31670189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are point-of-care urine drug testing devices suitable for antenatal drug screening? A study verifying the Alere® Drug Screen Test Cup for the detection of six classes of drug in a pregnant population.
    Dale RC; Ford LT; Street C
    Ann Clin Biochem; 2021 May; 58(3):166-173. PubMed ID: 33435699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meconium drug testing reveals maternal misuse of medicinal opioids among addicted mothers.
    Launiainen T; Nupponen I; Halmesmäki E; Ojanperä I
    Drug Test Anal; 2013 Jul; 5(7):529-33. PubMed ID: 23389850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioid detection in maternal and neonatal hair and meconium: characterization of an at-risk population and implications to fetal toxicology.
    Moller M; Karaskov T; Koren G
    Ther Drug Monit; 2010 Jun; 32(3):318-23. PubMed ID: 20418801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drugs of abuse testing in meconium.
    Gareri J; Klein J; Koren G
    Clin Chim Acta; 2006 Apr; 366(1-2):101-11. PubMed ID: 16413011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternative matrices for cocaine, heroin, and methadone in utero drug exposure detection.
    Concheiro M; González-Colmenero E; Lendoiro E; Concheiro-Guisán A; de Castro A; Cruz-Landeira A; López-Rivadulla M
    Ther Drug Monit; 2013 Aug; 35(4):502-9. PubMed ID: 23851907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug screening during pregnancy: Urine dip cups measure up.
    Kroska EB; Meller EW; Doyle R; Coker JL; Knight BT; Ray-Griffith SL; Nembhard WN; Stowe ZN
    Drug Alcohol Depend; 2019 Nov; 204():107461. PubMed ID: 31521952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.